Abo Bibliothek: Guest
International Journal for Multiscale Computational Engineering

Erscheint 6 Ausgaben pro Jahr

ISSN Druckformat: 1543-1649

ISSN Online: 1940-4352

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.4 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 1.3 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 2.2 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00034 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.46 SJR: 0.333 SNIP: 0.606 CiteScore™:: 3.1 H-Index: 31

Indexed in

ANERGY TO SYNERGY-THE ENERGY FUELING THE RXCOVEA FRAMEWORK

Volumen 18, Ausgabe 3, 2020, pp. 329-333
DOI: 10.1615/IntJMultCompEng.2020035097
Get accessDownload

ABSTRAKT

We write to introduce our novel group formed to confront some of the issues raised by the COVID-19 pandemic. Information about the group, which we named "cure COVid for Ever and for All" (RxCOVEA), its dynamic membership (changing regularly), and some of its activities-described in more technical detail for expert perusal and commentary-are available upon request.

REFERENZEN
  1. De Clercq, E. and Li, G., Approved Antiviral Drugs over the past 50 Years, Clin. Microbiol. Rev, vol. 29, no. 3, pp. 695-747, 2016.

  2. Du, S.Q. and Yuan, W., Mathematical Modeling of Interaction between Innate and Adaptive Immune Responses in COVID-19 and Implications for Viral Pathogenesis, J. Med. Virol., 2020 (ahead of print). DOI: 10.1002/jmv.25866.

  3. Gandhi, M., Yokoe, D.S., and Havlir, D.V., Asymptomatic Transmission, the Achilles' Heel of Current Strategies to Control COVID-19, N.Engl. J Med., 2020 (ahead of print). DOI: 10.1056/nejme2009758.

  4. He, X., Lau, E.H., Wu, P., Deng, X., Wang, J., Hao, X., Lau, Y.C., Wong, J.Y., Guan, Y., Tan, X., and Mo, X., Temporal Dynamics in Viral Shedding and Transmissibility of COVID-19, Nat. Med, vol. 26, no. 5, pp. 672-675, 2020.

  5. Jewell, N.P., Lewnard, J.A., and Jewell, B.L., Caution Warranted: Using the Institute for Health Metrics and Evaluation Model for Predicting the Course of the COVID-19 Pandemic, Ann. Intern. Med., 2020 (ahead of print). DOI: 10.7326/m20-1565.

  6. Zhavoronkov, A., Vanhaelen, Q., and Oprea, T.I., Will Artificial Intelligence for Drug Discovery Impact Clinical Pharmacology?, Clin. Pharmacol. Ther., vol. 107, no. 4, pp. 780-785,2020.

Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen Preise und Aborichtlinien Begell House Kontakt Language English 中文 Русский Português German French Spain